000 01122 a2200313 4500
005 20250513144158.0
264 0 _c19980701
008 199807s 0 0 eng d
022 _a0022-3476
024 7 _a10.1016/s0022-3476(98)70384-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGospe, S M
245 0 0 _aCurrent perspectives on pyridoxine-dependent seizures.
_h[electronic resource]
260 _bThe Journal of pediatrics
_cJun 1998
300 _a919-23 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnticonvulsants
_xtherapeutic use
650 0 4 _aGlutamate Decarboxylase
_xgenetics
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aPrevalence
650 0 4 _aPyridoxine
_xadministration & dosage
650 0 4 _aSeizures
_xdrug therapy
650 0 4 _aTreatment Outcome
650 0 4 _agamma-Aminobutyric Acid
_xdeficiency
773 0 _tThe Journal of pediatrics
_gvol. 132
_gno. 6
_gp. 919-23
856 4 0 _uhttps://doi.org/10.1016/s0022-3476(98)70384-1
_zAvailable from publisher's website
999 _c9593963
_d9593963